Related Experiment Video
Updated: Jul 26, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
Published on: May 3, 2018
White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study
P H Gustavsen1, A Høegholm, L E Bang
1Department of Internal Medicine, County Central Hospital, Naestved, Denmark. gustavsen@dadlnet.dk
Insights
White coat hypertension (WCH) patients face increased cardiovascular risk, similar to established hypertension, over a 10-year period. This finding contrasts with the benign prognosis previously suggested for WCH.
Area of Science:
- Cardiology
- Hypertension Research
- Preventive Medicine
Background:
- White coat hypertension (WCH) is characterized by elevated blood pressure (BP) in clinical settings but normal readings elsewhere.
- The long-term prognosis of WCH remains uncertain, with some studies suggesting it is benign.
Purpose of the Study:
- To evaluate the cardiovascular risk associated with white coat hypertension.
- To compare the long-term outcomes of WCH patients with established hypertension and normotensive controls.
Main Methods:
- A 10-year follow-up study involving 420 newly diagnosed hypertensive patients and 146 normotensive controls (NTs).
- Ambulatory blood pressure (ABP) monitoring was used at baseline to identify WCH using a cutoff of daytime-ABP <135/90 mmHg.
- Cardiovascular events, including deaths and nonfatal events, were recorded for all participants.
Main Results:
- The study identified 76 WCH patients (18.1%) and 344 established hypertensive (EH) patients.
- The WCH group experienced 18.4% first cardiovascular events, comparable to the EH group (16.3%) and significantly higher than the NT group (6.8%).
- Even with a lower ABP cutoff (135/85 mmHg), WCH remained associated with a significantly higher cardiovascular event rate.
Conclusions:
- White coat hypertension is associated with an increased cardiovascular risk compared to normotensive individuals.
- The cardiovascular risk in WCH is comparable to that observed in established hypertension.
- These findings challenge the notion that WCH is a benign condition.
Abstract:
The objective of this paper was to evaluate the cardiovascular risk in white coat hypertension (WCH). WCH is a well-known clinical entity defined by persistently elevated blood pressure (BP) in the doctor's office, whereas BP in other conditions is normal. The prognosis of WCH is unsettled, although two prospective studies that include normal control groups imply that the condition is benign. This study is a 10-year follow-up study on 420 patients with grade I-II hypertension newly diagnosed by their general practitioner and 146 normal controls (NTs). Ambulatory blood pressure (ABP) monitoring was performed at baseline. With our protocollated cutoff value of daytime-ABP <135/90 mmHg, 76 (18.1%) of the 420 hypertensives were white coat hypertensives (WCHs) and 344 were established hypertensives (EHs). With a lower cutoff of 135/85 mmHg, 40 (9.5%) were WCHs. Complete follow-up data were obtained for all 566 subjects. The mean duration of follow-up was 10.2 years (range 9.0-12.5). In the WCH group, 14 first events were recorded (18.4%) consisting of two cardiovascular deaths and 12 nonfatal cardiovascular events. In the EH group, the corresponding number of events were 56 first events (16.3%), 12 cardiovascular deaths and 44 nonfatal cardiovascular events, and in the NT group 10 first events (6.8%), two cardiovascular deaths and eight nonfatal cardiovascular events. The event rate was similar in the WCH group and the EH group and significantly lower in the NT group (P<0.05). When corrected for daytime-ABP, age and other confounders, the difference remained statistically significant. When using the lower cutoff of 135/85 mmHg, WCH was still associated with a significantly higher cardiovascular event rate. In conclusion, the main finding of this 10-year follow-up study is an increased cardiovascular risk in WCH compared to normotensive controls.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies

